SAVA FY 2022 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$116M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$68M

Operating Income

-$80M

Net Income

-$76M

EPS (Diluted)

$-1.80

Cash Flow

Operating Cash Flow

-$78M

Free Cash Flow

-$80M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$235M

Total Liabilities

$7M

Stockholders' Equity

$228M

Cash & Equivalents

$201M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$68M	$0	—
Operating Income	-$80M	-$33M	-143.5%
Net Income	-$76M	-$32M	-135.4%